ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.33
1.50%
US Tech 100
19,167.20
2.31%
S&P 500
5,638.94
2.13%
US Dollar vs CAD
1.43875
0.00%
Bitcoin
83,949.71
-0.01%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Alto Neuroscience Inc (ANRO) Share Price

Alto Neuroscience Inc

Alto Neuroscience Inc (ANRO)

NYSE
3.17
0.01
(0.32%)
Closed March 15 3:00PM
Delayed by 15 minutes
3.07
-0.10
(-3.15%)
After Hours: 6:27PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.07
Bid
-
Ask
-
Volume
138,732
3.10 Day's Range 3.29
2.67 52 Week Range 18.3499
Market Cap
82.798M
Previous Close
3.16
Open
3.23
Last Trade
150
@
3.07
(formt)
Last Trade Time
Financial Volume
US$ 439,763
VWAP
3.1699
Average Volume (3m)
309,728
Shares Outstanding
26,970,168
Dividend Yield
-
PE Ratio
-2.35
Earnings Per Share (EPS)
-1.35
Revenue
-
Net Profit
-36.31M

About Alto Neuroscience Inc

Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients' b... Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients' brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.altoneuroscience.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Alto Neuroscience Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker ANRO. The last closing price for Alto Neuroscience was US$3.16. Over the last year, Alto Neuroscience shares have traded in a share price range of US$ 2.67 to US$ 18.3499.

Alto Neuroscience currently has 26,970,168 shares outstanding. The market capitalization of Alto Neuroscience is US$85.23 million. Alto Neuroscience has a price to earnings ratio (PE ratio) of -2.35.

Ask ADVFN Intelligence (AI)

ANRO Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
February 12 2025
ANRO (0.32%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
February 11 2025
ANRO (0.32%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 07 2025
ANRO (0.32%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 07 2025
ANRO (0.32%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 07 2025
ANRO (0.32%)

Form 8-K - Current report
Edgar (US Regulatory)
February 03 2025
ANRO (0.32%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.03-25.12195121954.14.12913.033203263.40437401CS
4-0.19-5.82822085893.264.12912.674348413.24570896CS
12-0.69-18.35106382983.764.882.673097283.67624618CS
26-11.005-78.18827708714.07515.042.675575115.98652694CS
52-10.87-77.977044476313.9418.34992.673639767.65067095CS
156-18.93-86.045454545522242.673573768.41804282CS
260-18.93-86.045454545522242.673573768.41804282CS

ANRO - Frequently Asked Questions (FAQ)

What is the current Alto Neuroscience share price?
The current share price of Alto Neuroscience is US$ 3.07
How many Alto Neuroscience shares are in issue?
Alto Neuroscience has 26,970,168 shares in issue
What is the market cap of Alto Neuroscience?
The market capitalisation of Alto Neuroscience is USD 85.23M
What is the 1 year trading range for Alto Neuroscience share price?
Alto Neuroscience has traded in the range of US$ 2.67 to US$ 18.3499 during the past year
What is the PE ratio of Alto Neuroscience?
The price to earnings ratio of Alto Neuroscience is -2.35
What is the reporting currency for Alto Neuroscience?
Alto Neuroscience reports financial results in USD
What is the latest annual profit for Alto Neuroscience?
The latest annual profit of Alto Neuroscience is USD -36.31M
What is the registered address of Alto Neuroscience?
The registered address for Alto Neuroscience is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Alto Neuroscience website address?
The website address for Alto Neuroscience is www.altoneuroscience.com
Which industry sector does Alto Neuroscience operate in?
Alto Neuroscience operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QBTSD Wave Quantum Inc
US$ 10.16
(47.03%)
261.24M
RBRKRubrik Inc
US$ 70.56
(27.64%)
7.27M
DMDesktop Metal Inc
US$ 2.4793
(21.53%)
651.82k
PDPagerDuty Inc
US$ 18.41
(17.94%)
4.37M
IONQIonQ Inc
US$ 25.00
(16.99%)
37.8M
XPOFXponential Fitness Inc
US$ 7.46
(-38.45%)
6.97M
NEUENeuehealth Inc
US$ 5.09
(-23.17%)
242.23k
SOLEmeren Group Ltd
US$ 1.18
(-19.73%)
1.23M
SKLZSkillz Inc
US$ 4.39
(-14.09%)
329.45k
TLYSTillys Inc
US$ 2.44
(-7.58%)
309.92k
QBTSD Wave Quantum Inc
US$ 10.16
(47.03%)
261.24M
FFord Motor Company
US$ 9.72
(1.99%)
91.31M
BBAIBigBear ai Holdings Inc
US$ 3.525
(7.80%)
55.12M
NUNu Holdings Ltd
US$ 11.72
(9.02%)
53.74M
NIONIO Inc
US$ 4.895
(3.49%)
53.62M

Discussion

View Full Feed
Investor2014 Investor2014 5 minutes ago
Yes and of course given your posting history here I fully expect you must be making groundbreaking contribution to the world too.
AVXL
edbi46 edbi46 5 minutes ago
On REDDIT 3 months ago:
RecoveryRx now available through prosthetics for pain management, ortho, PT
Veterans Health Administration
VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an el
BMI LMT QUBT
Pink Lady Pink Lady 6 minutes ago
You silly little boy...
that you come now and say these things. And when you call out on someone please have the courage to tag him instead of talking behind his back
@stervc
MONI
hardlesson hardlesson 11 minutes ago
Hey, where have you been? I'm assuming you're still hanging on to a large stack of shares here?

Turned out to be a huge disappointment for me so far, but hope things turn around for those that deserve a reward for holding so long.

Management has disrespected sharehol
SHMN
Researchfyi Researchfyi 20 minutes ago
n case anyone missed it the ring company closed at a new all time low of 0.1766 cents on Friday and had a record low on Thursday of 0.172 cents.

Which poster here touted and shouted that the ring company was a screaming buy and that you had to be a fool more or less for not buying, wh
LQMT
getmenews getmenews 34 minutes ago
Dear World Liberty, It's time to advise what the strategic reserve implies when you mean it will be a reserve, it will be your reserve right?
BTCUSD
joyceschoice joyceschoice 1 hour ago
https://www.youtube.com/watch?v=4ymPHzIkvug
CaptBeer CaptBeer 1 hour ago
That's the other shoe that will drop just like they did in the previous MARINE Patents trial. Only this time we hope our counsel will be ready for schenanegans like cropped tables. 
AMRN
wshaw14 wshaw14 1 hour ago
While the following is true "You will have to recapture all the depreciation and capital gains" except 0% Rate: Single filers with taxable income up to $48,350; Married filing jointly up to $96,700; Married filing separately up to $48,3503. This means for example if one is married and over 65 person
ET
getmenews getmenews 1 hour ago
I don't suspect we see 2.50 again till after the BR filing, all the other ETF filings are non events!

Nice day
XRPUSD
getmenews getmenews 1 hour ago
So where to next? Lower support line in my charts, which, I know you see!

Nice day
XRPUSD
JusticeWillWin JusticeWillWin 1 hour ago
Be safe!

Up to like 7 or 8 fires now NOPEY well over 10 now
COOP
Mr79 Mr79 1 hour ago
https://media3.giphy.com/media/f6W3eijFZUIwiNY0xp/giphy.gif?cid=6c09b952klfx6y7jxsop94baxo5k1w85a23kjntrjlfprodb&ep=v1_internal_gif_by_id&rid=giphy.gif&ct=g
CNNA
Slojab Slojab 1 hour ago
Yeah, perhaps the guy is fabricating the story. But like you said, you wouldn't be at all surprised if it were true. And to even think it is, is pretty telling.
CosmicWatcher161 CosmicWatcher161 1 hour ago
Seems like a new 2024 annual report is added

https://s204.q4cdn.com/707617056/files/doc_financials/2024/ar/8e6783e2-86ea-429d-90cc-46b2afae5e0d.pdf
SMCI
WooptdooU WooptdooU 1 hour ago
Yve's answer to whether the product is ready? "We think so", is a defense. Like I say, it'll be interesting to watch an expert witness testify against expert witness, grifter, misguider, dr, dr lebby.
LWLG
Lykiri Lykiri 1 hour ago
Thanks for sharing pgsd.
https://x.com/Siobhain_Mc/status/1900610727351615512

https://commonslibrary.parliament.uk/research-briefings/cbp-10198/
NWBO
Lykiri Lykiri 2 hours ago
You're not the only one wondering why the MHRA is taking so long. Even MP Siobhain McDonagh called their performance on glioblastoma 'woeful' and questioned whether they should be abolished altogether.

March 13
https://x.com/Siobhain_Mc/status/1900226965656813953
NWBO
Investor2014 Investor2014 2 hours ago
On top of Missling having no fallback revenue opportunities without EMA approval from current trials, a share buyback would be just about the best way to erode the company's cash balance and ability to fund new trials.
AVXL
maverick_1 maverick_1 2 hours ago
PROFOUND Implications of CO Mingling two heretofore separate & distinct therapies
CELL & GENE ( latter is approaching a decade in development & approved in many blood cancers)

Perhaps why $NWBO MAESTRO spent 2 years in negotiations for mid 2024 Cross Licensing with Roswell Pa
NWBO
nowwhat2 nowwhat2 2 hours ago
wth
BKMT
joyceschoice joyceschoice 2 hours ago
https://www.youtube.com/watch?v=xZlxOvHwcq0
nowwhat2 nowwhat2 2 hours ago
wow.....that was 9 years ago.....Now what ?
https://www.mining.com/pdac-jv-video-dundee-sustainables-clevr-chemistry-cuts-gold-extraction-time-to-an-hour/
Holy
https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=ca%3Adst&x=0&y=0&time=100&startd
DST
facts_matter14 facts_matter14 2 hours ago
Misery loves company and the 5 of them are surely miserable with their 99% losses.

FACTS are always here to trump their bullshit.

Can you believe this POS is down 99%, loses over $100,000 per month, has no cash and no sources of funding except for one Taiwanese dude, an
SRMX
dalesio_98 dalesio_98 2 hours ago
Interesting, care to share actual proof attorneys are posting at this BioAmber Inc fka BIOAQ forum.

Attorneys posting on a indepted shell for half a decade.

Your Recent History

NYSE
ANRO
Alto Neuroscience
LSE
MNKS
Monks Investment
NYSE
GCTS
Wts each whole warrant e...
BIT
UB3JUG
UniCredit Bank
BIT
P1TLM3
BNP Paribas Issuance
BOV
A1TT34M
Allstate
LSE
RTC
Rtc
BIT
S32553
Societe Generale Effekten
BIT
UC4VDM
Unicredit Bank
EU
AUB8L
Amundi Finance Emissions...
NASDAQ
ABKVWXX
Bank of Montreal Capped ...
BIT
UB60NE
Unicredit Bank
BIT
P1IZB9
BNP Paribas Issuance
EU
AFLAZ
Agence France Locale Dom...
TSXV
IBIT
Interbit
USOTC
AWSL
Atlantic Power and Infra... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads